Rectal cancer with paraneoplastic nephropathy: association of vascular endothelial growth factor

Dig Surg. 2004;21(5-6):455-7. doi: 10.1159/000083474. Epub 2005 Jan 19.

Abstract

A patient with advanced rectal cancer was complicated by progressing proteinuria and hypoproteinemia. Low anterior resection was a procedure of choice. A surgical specimen obtained by intraoperative renal biopsy showed the findings of minimal change nephrotic syndrome. After surgery, nephropathy remitted promptly and completely. Her pre/postoperative serum level of vascular endothelial growth factor was 1,880/52.3 pg/ml, suggesting its elevation was associated with the nephropathy. Immunohistochemistry revealed strongly expressed tumor vascular endothelial cell growth factor. Minimal change nephrotic syndrome is a rare type of paraneoplastic nephropathy, and successful remission may require therapeutic resection of the underlying tumor, or administration of a vascular endothelial growth factor antagonist if the tumor is unresectable.

Publication types

  • Case Reports

MeSH terms

  • Female
  • Humans
  • Immunohistochemistry
  • Middle Aged
  • Nephrosis, Lipoid / epidemiology
  • Nephrosis, Lipoid / metabolism
  • Nephrosis, Lipoid / physiopathology*
  • Nephrosis, Lipoid / surgery*
  • Paraneoplastic Syndromes / metabolism
  • Paraneoplastic Syndromes / physiopathology*
  • Paraneoplastic Syndromes / surgery*
  • Rectal Neoplasms / diagnosis
  • Rectal Neoplasms / epidemiology
  • Rectal Neoplasms / physiopathology*
  • Rectal Neoplasms / surgery
  • Vascular Endothelial Growth Factor A / blood
  • Vascular Endothelial Growth Factor A / metabolism
  • Vascular Endothelial Growth Factor A / physiology*

Substances

  • Vascular Endothelial Growth Factor A